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1. Introduction  
G-protein-coupled receptors (GPCRs) comprise a large family of cell-surface molecules, 
involved in signal transmission, accounting for >2% of the total genes encoded by the 
human genome.  GPCRs have been linked to key physiological functions, including immune 
responses, cardiac- and smooth-muscle contraction and blood pressure regulation, 
neurotransmission, hormone and enzyme release from endocrine and exocrine glands. Thus, 
GPCRs contribute to embryogenesis, tissue remodelling and repair, inflammation, 
angiogenesis and normal cell growth. Their dysfunction contributes to multiple human 
diseases, and  GPCRs represent the target of  over 50% of all current therapeutic agents 
(Reviewed by Pierce et al., 2002). In addition, recent studies indicate that many GPCRs are 
overexpressed in various cancer types, and contribute to tumor cell growth when activated 
by circulating or locally produced ligands, suggesting a crucial role of GPCRs in cancer 
progression and metastasis. For example, many potent mitogens such as thrombin, 
lysophosphatidic acid (LPA), endothelin and prostaglandins stimulate cell proliferation by 
acting on their cognate GPCRs in various cell types.  (Reviewed by Dorsam & Gutkind, 
2007). The mechanisms that control cellular proliferation are important in normal 
physiology and disease states. Multiple mitogens that activate GPCRs stimulate the 
extracellular signal-regulated protein kinase (ERK) and lead to proliferation of mammalian 
cells. Another extensively studied mitogenic effector pathway in addition to ERK that 
ultimately leads to cell proliferation, is the ubiquitous plasma membrane sodium-proton 
exchanger type 1 (NHE1). NHE1 and ERK have both been implicated as key mediators of 
growth signals (Noel & Pouyssegur, 1995; Rozengurt, 1986; Kapus et al, 1994; Krump et al, 
1997), therefore the regulatory relationships between NHE1 and ERK have been the subject 
of a number of studies over the last decade. Because both proteins can serve mitogenic 
functions, and because both are activated by similar stimuli, it has been hypothesized that 
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one may be a regulator for the other. Indeed, in some cell types  ERK plays a clear role in 
either the short or long term activation of NHE1 (Aharonovitz & Granot, 1996; Bianchini et 
al., 1997; Wang et al., 1997; Sabri et al., 1998; Bouaboula et al., 1999; Gekle et al., 2001). 
However, several groups were unable to demonstrate any role of ERK in regulation of 
NHE1 in a number of  cell types (Gillis et al., 2001; Kang et al., 1998; Pederson et al., 2002; 
Garnovskaya et al., 1998; Di Sario et al., 2003). In addition, a number of recent studies 
suggested that certain stimuli such as mechanical stretch, hypertrophy and inflammatory 
mediators require NHE1 to regulate ERK (Takewaki et al., 1995; Nemeth et al., 2002; 
Yamazaki et al., 1998; Javadov et al., 2006; Chen et al., 2007). At present, very little is known 
about GPCR-induced NHE1-dependent ERK regulation. One report suggests that NHE1 is 
not a regulator for LPA-induced ERK activation in C6 glioma cells (Cechin et al., 2005) and 
another paper demonstrates the lack of role of NHE1 in angiotensin II (Ang II)- and 
endothelin 1-induced ERK activation in cultured neonatal rat cardiomyocytes (Chen et al., 
2007). At the same time, our group showed that NHE1 activation plays a necessary role in 
activation of ERK by AII AT1 and serotonin 5-HT2A receptors in vascular smooth muscle 
cells (VSMC) (Mukhin  et al., 2004), and in bradykinin B2 receptor-induced ERK activation in 
renal carcinoma A498 cells (Garnovskaya et al., 2008) thus suggesting that the critical role of 
NHE1 in GPCR-induced ERK activation is not restricted to one specific cell type and 
receptor. Studies on the involvement of NHE1 in ERK regulation may also have 
pathophysiological relevance. NHE1 is usually referred to as a “housekeeping” protein and 
is normally inactive, but it gets activated  in response to multiple specific stimuli, and 
maintains homeostatic cell volume and pH through Na+/H+ transport. The role of NHE1 
has been well established in the myocardial remodeling and heart failure process (reviewed 
by Karmazyn et al., 2008). NHE1 may play a key role in the maintenance of blood pressure 
because increased activity of NHE1 has been observed in cells and tissues from hypertensive 
animals and humans (Rosskopf, et al., 1993; Lucchesi et al., 1994). Northern blot analysis 
showed that cultured VSMC from Sprague-Dawley and Wistar-Kyoto rats express only the 
NHE1 isoform, and that steady-state mRNA levels are similar for normal and spontaneously 
hypertensive animals (Lucchesi et al., 1994; LaPointe et al., 1995). Because no mutations in 
the NHE1 DNA sequence have been found in hypertensive animals, this suggests that 
increased activity of the antiporter is caused by an alteration in the regulation of NHE1 
(Lucchesi et al., 1994). In addition, NHE1-mediated intracellular alkalinization has been 
proposed to play role in cancer cells growth, and over-expression of NHE1 contributes to 
the transformed phenotype of multiple cancer cells (Cardone et al., 2005). The role of NHE1 
in renal diseases is less known. Mice with a spontaneous point mutation that results in 
truncation between the 11th and 12th NHE1 trans-membrane domains and causes loss of 
NHE1 function (Cox et al., 1997) do not present visible renal phenotype, consistent with the 
concept that NHE1 “housekeeping” activity under normal conditions is not required. 
However, NHE1 activity was increased in cell lines derived from patients with diabetic 
nephropathy (Ng et al., 1994), suggesting that NHE1 activity may be important in the 
context of cellular stress. Further, it has been shown that genetic or pharmacological loss of 
NHE1 function causes renal tubule epithelial cell apoptosis and renal dysfunction in several 
models of kidney disease (ureteral obstruction, adriamycin-induced podocyte toxicity, and 
streptozotocin-induced diabetes), suggesting that NHE1 activity may be beneficial for 
chronic kidney disease (Schelling & Abu, 2008). Moreover both, ERK and NHE1, have been 
www.intechopen.com
G Protein-Coupled Receptors-Induced Activation of Extracellular  
Signal-Regulated Protein Kinase (ERK) and Sodium-Proton Exchanger Type 1 (NHE1) 237 
proposed as key therapeutic targets for  vascular illnesses, such as congestive heart failure ( 
Kusumoto et al., 2001), myocardial infraction and reperfusion injury (Avkiran & Marber, 
2002),  ventricular fibrillation (Gazmuri et al., 2001), and ventricular hypertrophy (Chen et 
al., 2001). Therefore, studies devoted to the regulatory relationships between NHE1 and 
ERK  have a potential clinical relevance. 
The purpose of this review is to describe the relationship between NHE1 and ERK when 
both pathways are activated by GPCRs, with a particular emphasis on the situations when 
NHE1 is regulating ERK activity leading to cell proliferation.  
2. Mitogen-activated protein kinases and Sodium-Hydrogen Exchanger-1 as 
mediators of growth signals 
2.1 Mitogen-activated protein kinases 
Mitogen-activated protein kinases (MAPKs) are a family of highly conserved proline-
directed serine/threonine kinases that are activated by a large variety of extracellular 
stimuli and play integral roles in controlling many cellular processes, from the cell surface to 
the nucleus (Widmann et al, 1999). The MAPK family in mammals includes four distinctly 
regulated groups of MAPKs: extracellular signal-regulated kinase 1/2 (ERK), p38, c-Jun N-
terminal kinases/stress-activated protein kinases (JNK/SAPKs), and ERK5/Big MAPK 
(BMK1) (Chang & Karin, 2001; Bogoyevitch & Court, 2004; Johnson & Lapadat, 2002). 
MAPK cascades typically consist of three levels of protein kinases that are consecutively 
activated by phosphorylation events: MAPK kinase kinase (MAPKKK or MAP3K or MEKK) 
activates MAPK kinase (MAPKK (MKK or MEK) or MAP2K), which in turn activates MAPK 
(Figure 1). Even so, the different tiers are composed of many similar isoforms that can be 
activated by more than one MAPK, increasing the complexity and diversity of MAPK 
signaling. Regulation and function of different MAPKs as well as complexity of MAPK 
signaling have been recently discribed in several review articles    (Pearson et al., 2001; 
Chang & Karin 2001; Shaul & Seger, 2007; Bodart; 2010). MAPKs are involved in 
transmitting signals from a wide variety of extracellular stimuli including those of growth 
factor receptors and GPCRs, as well as physical or mechanical stimuli.  In fact, MAPKs are 
major components of signaling pathways regulating a large array of intracellular events, 
such as proliferation, differentiation, acute signaling in response to hormones, stress 
response, programmed cell death, and gene expression (Pearson et al., 2001; Chang & Karin 
2001; Kim & Choi, 2010). ERK is one member of a family of kinases that participate in 
mitogenic signaling through complex phosphorylation cascades that convert cell surface 
signals into nuclear transcription programs. In the typical scenario, GTP-bound Ras, a small 
G protein, activates Raf-1 kinase. In an alternative scenario, protein kinase C (PKC) or other 
signaling molecules activate Raf-1. In either case, Raf-1 phosphorylates and activates 
mitogen and extracellular signal-regulated kinases kinase (MEK), which in turn 
phosphorylates and activates ERK (Cobb & Goldsmith, 1995). Activated ERK translocates to 
the nucleus, where it activates a number of transcription factors such as Elk-1. 
Recently a number of scaffolding proteins that play important role in   ERK regulation have 
been described. Examples of such proteins include the Kinase Suppressor of Ras (KSR), β-
arrestins1/2, PEA15 (phosphoprotein enriched in astrocytes), paxillin, and Raf-1 ( Kolch, 
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2005).  Paxillin, a multi adaptor protein in focal adhesion assembly,  serves as a connector 
between ERK and Focal Adhesion Kinase (FAK) signaling pathways binding Raf-1 and ERK 
in response to hepatocyte growth factor in epithelial cells  (Ishibe et al., 2004).  
 
 
Fig. 1. Mitogen-Activated Protein Kinase Cascades. 
2.1.1 Regulation of ERK by GPCRs 
The ability of G-protein-coupled receptors (GPCRs) to generate signals that control cellular 
proliferation via activation of ERK  pathways has been demonstrated in several studies  
(reviewed by Kranenburg & Moolenaar, 2001;  and Luttrell, 2002). Although the 
mechanisms by which GPCRs control the activity of ERK vary between receptor and cell 
type, typically there are three categories of mechanisms: (1) signals that initiate classical G 
protein effectors, e.g., protein kinase A or protein kinase C causing the production of second 
messengers,  (2) mechanisms that involve cross-talk between GPCRs and classical receptor 
tyrosine kinases, e.g., "transactivation" of epidermal growth factor (EGF) receptors, and  (3) 
signals initiated by direct interaction between beta-arrestins and components of the MAP 
kinase cascade, e.g., beta-arrestin "scaffolds". Mitogenic pathways activated by different Gǂ 
families including activation of adenylyl cyclase/cAMP and phospholipase Cǃ/protein 
kinase C second messenger pathways have been described in detail (reviewed by New & 
Wong, 2007).  Angiotensin II promotes DNA synthesis and proliferation in many cell types 
by activating the Gq-coupled AT1 receptor. AT1 receptor activity in human adrenal cells 
induces Ras-dependent ERK activity, leading to increased levels of c-Fos and c-Jun 
transcription factors and to proliferation of the cells (Watanabe et al., 1996). Other mitogenic 
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GPCRs, including M1 muscarinic and ǂ1B-adrenergic and purinergic receptors, induce ERK 
activity via the Ras-independent protein kinase C  phosphorylation and activation of Raf-1 
(Luttrell, 2002). Gs-coupled GPCRs utilize the adenylyl cyclase/ cAMP /Epac/Rap-1/B-Raf 
pathway to activate MAPK cascades and proliferation. In bone cells  parathyroid hormone 
receptor promotes cAMP accumulation, which binds directly to the Rap-1 guanine 
nucleotide exchange factor Epac. Epac in turn activates Rap-1, a Ras family GTPase, which 
activates the kinase B-Raf, triggering ERK cascades (Fujita et al., 2002). Alternatively, PKA 
may directly activate Rap-1 (Luttrell, 2002).  
However, activation of classical second messenger cascades cannot fully explain roles of 
GPCRs in stimulation of MAPK cascades. Additional signaling mechanisms including 
transactivation of the Receptor Tyrosine Kinases (RTKs) via the autocrine/paracrine release of 
epidermal growth factor (EGF)-like ligands at the cell surface and scaffolding of MAPK 
cascades, appear to contribute to GPCR-mediated MAPK activation. GPCR-mediated 
proliferation via the Gα or Gβγ subunit transactivation of RTKs  has been described in several 
cell types (Ohtsu et al., 2006; Schafer et al., 2004). Thus, ligands for the LPA, endothelin-1 and 
thrombin receptors all stimulate cell proliferation in Rat-1 fibroblasts by transactivation of the 
epidermal growth factor receptor (EGFR, an RTK). Such transactivation requires the activation 
of matrix metalloproteases (MMPs) to release EGF from its membrane bound form, which then 
stimulates the EGFR and downstream ERK pathways (Schafer et al., 2004). Studies from our 
group demonstrated that bradykinin B2 receptor activates ERK via EGFR transactivation in 
kidney cells (Mukhin et al., 2003; Mukhin et al., 2006; Kramarenko et al., 2010). The  similar 
MMP/EGFR/ERK pathway have been also demonstrated in kidney cancer cells stimulated by 
LPA and angiotensin II (Schafer et al., 2004). A significant advance in the understanding of 
how GPCRs activate MAPK cascades is the discovery that  beta-arrestin, a protein well known 
for its roles in both receptor desensitization and internalization, serves as a scaffolding protein 
for the  GPCR-stimulated the extracellular signal regulated kinase ERK cascade. For example, 
agonist stimulation of the proteinase-activated receptor-2 (PAR2) leads to the formation of a 
large complex, which includes the receptor and beta-arrestin, MAPKKK, Raf-1, and activated 
ERK.  Similarly, activation of neurokinin-1 receptor with the substance P, results in the 
formation of a complex, which includes the receptor, and beta-arrestin, c-Src and ERK. 
(Reviewed by Pierce et al., 2001). 
ERK activation occurring via EGF receptor transactivation or via pathways employing second 
messengers (PKA- or PKC-dependent pathways) typically leads to sustained ERK activity and 
nuclear translocation of the kinase, thus contributing to regulation of cell cycle progression 
(Kranenburg & Moolenaar, 2001; Luttrell, 2002). In contrast, beta-arrestin/endocytotic 
pathway usually results in the retention of ERK in the cytoplasm and transient ERK activity, 
which is probably not sufficient to stimulate cell proliferation (Luttrell, 2002).  
The intracellular pathways that mediate GPCR -induced  ERK activation and regulation of 
cellular proliferation were recently reviewed by New & Wong (New & Wong, 2007). 
2.2 Sodium-Hydrogen Exchanger-1 (NHE1)  
The Na+/H+ exchange system was described in 1977 by Aickin and Thomas (Aickin & 
Thomas, et al., 1977), and the first Na+/H+ exchanger (NHE) gene was cloned in 1989 (Sarget 
et al., 1989). To date nine mammalian isoforms (NHE 1-9) have been identified in the family 
of Na+/H+ exchangers (Kemp et al, 2008). In this review we will focus only on the 
www.intechopen.com
 Current Frontiers and Perspectives in Cell Biology 240 
ubiquitously expressed, amiloride-sensitive integral plasma membrane protein NHE1 
known as the "housekeeping enzyme", which is activated by various stimuli including 
growth factors, mitogens, and hyperosmolarity (Orlowski & Grinshtein, 2004; Wakabayashi 
et al., 1997).  NHE1 is  highly conserved across vertebrate species and is a major membrane 
transport mechanism, which plays an essential role in pH regulation, volume homeostasis, 
cell growth and differentiation (Bertrand et al., 1994). NHE1 is a phosphoglycoprotein of 815 
amino acids that contains two functional domains: an NH2-terminal transmembrane ion 
translocation region with a proposed topology of 12 transmembrane domains, and a COOH-
terminal cytoplasmic regulatory domain (Figure 2). The ion translocation domain catalyzes 
electroneutral exchange of extracellular sodium ion for intracellular hydrogen. Regulation of 
NHE1 activity in response to multiple stimuli including growth factors, hormones, and 
osmotic stress is mediated by a COOH-terminal cytoplasmic regulatory domain.  The 
regulatory domain controls transport activity probably by altering affinity of a proton site in 
the transmembrane domain (Takahashi et al., 1999). This cytoplasmic domain includes a 
number of distinct subdomains modified either by phosphorylation or by the binding of 
regulatory proteins. The cytoplasmic domain contains high and low affinity 
Ca2+/calmodulin-binding sites and several potential phosphorylation sites (Bertrand et al., 
1994; Yan et al., 2001). Bertrand et al. first identified two calmodulin-binding sites on the 
  
 
Fig. 2. Topographical model of NHE1. 
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cytoplasmic domain of NHE1 at amino acids 636-656 and 664-684, with high (Kd ~ 20 nM) 
and low (Kd~ 350 nM) affinities, respectively (Bertrand et al., 1994). In quiescent cells, the 
high-affinity calmodulin-binding domain may act as an autoinhibitory domain by 
interacting with the transmembrane domain, thus inhibiting ion translocation. Upon 
activation, NHE1 undergoes a conformational change that allows the Ca2+ -dependent  
binding of calmodulin (Wakabayashi et al., 1997). A phosphorylation domain at the distal 
COOH-terminus (amino acids 656-815 of human NHE1) contains a number of serine 
residues constitutively phosphorylated in quiescent cells that have increased 
phosphorylation levels in response to growth factors (Sarget et al., 1989). COOH-terminal 
serine residues on NHE1 molecule can be phosphorylated by the ERK-regulated kinase 
p90RSK (Tominaga et al., 1998) and by the Ste20-like Nck-interacting kinase (NIK) in 
response to growth factor receptors (Putney et al., 2002) and by Rho kinase 1 (ROCK1) in 
response to activation by GPCRs for thrombin and lysophosphatidic acid (Tominaga et al., 
1998; Putney et al., 2002) and by integrin-induced cell adhesion (Tominaga & Barber, 1998). 
Because the cytoplasmic regulatory domain associates with multiple binding partners 
including the cytoskeleton-plasma membrane linker protein ezrin of the ezrin, moesin, 
radixin, (EMR) family (Denker et al., 2000), the calcineurin homolog protein CHP1 (Pang et 
al., 2001), calmodulin (CaM) (Yan et al., 2001), carbonic anhydrase II (Li et al., 2002), heat 
shock protein (Silva et al., 1995),  and 14-3-3 protein (Lehoux et al., 2001), a novel function of 
NHE1 as a plasma membrane scaffold in the assembly of signaling complexes has been 
suggested (Baumgartner et al., 2004). 
2.2.1 Regulation of NHE1 by GPCRs 
While the activation of NHE1 and the kinetic alterations to the exchanger have been widely 
studied (Noel & Pouyssegur, 1995; Wakabayashi et al., 1997; Orlowski & Grinshtein, 1997) 
the signaling pathways that regulate NHE1 have not been fully elucidated. Because G 
protein-coupled receptors (GPCRs)-mediated regulation of sarcolemmal NHE activity is 
likely to play significant roles in modulating myocardial function in both physiological and 
pathophysiological conditions,  most of the studies devoted to GPCR-induced NHE1 
regulation were performed in cardiac myocytes (reviewed by Avkiran & Haworth, 2003).  
Sarcolemmal NHE activity is subject to exquisite regulation by a variety of extracellular 
stimuli, most of which act through GPCRs. Intriguingly, although the majority of the GPCR 
systems that have been studied to date have been shown to stimulate sarcolemmal NHE 
activity, there is also evidence that some may inhibit NHE activity or its stimulation through 
other pathways. A number of GPCRs, such as  α1-adrenergic receptors , angiotensin II AT1 
receptors, endothelin ETA receptor,  thrombin  receptor, muscarinic receptors have been 
shown to increase sarcolemmal NHE activity through a change in the pHi sensitivity of the 
exchanger. Interestingly, in contrast to the evidence that various Gq –coupled receptors (e.g. 
α1A-ARs and angiotensin AT1) mediate an increase in sarcolemmal NHE activity, GPCRs 
that signal through other G protein families (Gs and Gi) may attenuate NHE activity or its 
stimulation. Thus, β1-AR stimulation inhibits sarcolemmal NHE activity, while adenosine A1 
and angiotensin AT2 receptors attenuate stimulation of NHE1 by other ligands (Avkiran& 
Haworth, 2003). The mechanisms of GPCR-induced NHE1 activation are not fully 
understood. To date, several mechanisms of activation of NHE1 by G protein-coupled 
receptors  have been proposed although not fully characterized : α1A-adrenoceptor  activates 
NHE1 through protein kinase C (Snabaitis et al., 2000; Avkiran & Haworth, 2003); 
lysophosphatidic acid   stimulates NHE1 through RhoA and its effector ROCK (Tominaga et 
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al., 1998),  and angiotensin II AT1 receptor regulates NHE1 activity through  RSK (Takahashi 
et al., 1999). In addition, Wallert et al provided evidence that the specific α1-adrenergic 
agonist, phenylephrine and the lysophosphatidic acid (LPA) activate NHE1 in CCL39 cells, 
and demonstrated a direct involvement of ERK in the α1-adrenergic activation of NHE1 and 
a significant role for both ERK and RhoA in LPA stimulation of NHE1 in CCL39 fibroblasts 
(Wallert et al., 2004). Our group reported that a fibroblast NHE1 can be rapidly stimulated 
through the transfected human serotonin 5-HT1A receptor via pertussis toxin-sensitive G 
protein α-subunits Giα2 and Giα3, in CHO cells (Garnovskaya et al., 1997), by endogenously 
expressed Gq-coupled bradykinin B2 receptor in kidney cells (Mukhin et al., 2001), and by 
endogenously expressed Gq-coupled angiotensin II  AT1 and serotonin 5-HT2A receptors in 
vascular smooth muscle cells (Garnovskaya et al., 2003). While studying the signaling 
pathway of bradykinin B2 receptor-induced NHE1 activation in mIMCD-3 kidney cells, we 
found a new mechanism for the GPCR-induced regulation of Na+/H+ exchange (Mukhin et 
al., 2001). This novel pathway involved  activation of phospholipase C, elevation of 
intracellular Ca2+, activation of the non receptor tyrosine kinase, Janus kinase 2 (Jak2), 
tyrosine phosphorylation of Ca2+/calmodulin (CaM), and binding of CaM to NHE1. 
Bradykinin rapidly stimulated the assembly of a signal transduction complex that includes 
CaM, Jak2, and NHE1. We suggested that Janus kinase 2 is involved in the activation of 
NHE1 by increasing the tyrosine phosphorylation of calmodulin, which appears to be a 
direct substrate for phosphorylation by Janus kinase 2.  Further the same pathway has been 
demonstrated for the bradykinin B2 receptor-mediated activation of Na+/H+ exchange in 
KNRK and CHO cells ( Lefler et al., 2003), and  for  the Gq-coupled angiotensin II  AT1 and 
serotonin 5-HT2A receptors, which  stimulated  NHE1 activation in vascular smooth muscle 
cells (Garnovskaya et al., 2003), suggesting that this pathway represent a fundamental 
mechanism for the rapid regulation of NHE1 by Gq-coupled receptors in multiple cell types. 
Further we have shown that the Gi – coupled serotonin 5-HT1A receptor also rapidly 
stimulates NHE1 through a pathway that involves 1) activation of Janus kinase 2 
downstream of the 5-HT1A receptor; 2) formation of a complex that includes NHE1, Jak2, 
and CaM; 3) tyrosine phosphorylation of CaM through Jak2; and 4) increased binding of 
CaM to the carboxyl terminus of NHE1 (Turner et al., 2007). 
2.3 Relationships between NHE1 and ERK 
2.3.1 MAPK regulates NHE1 
Whereas it has been known for some time that mitogens typically activate both NHE1 and 
ERK in concert (Noel & Pouyssegur, 1995; Rozengurt, 1986; Kapus et al., 1994; Krump et al., 
1997) the exact relationships between NHE1 and ERK have only recently been explored in 
any great detail. Recent studies have shown that multiple stimuli that rapidly activate ERK 
pathways also rapidly increase NHE activity in many cell types, particularly in fibroblasts. 
Those stimuli include, but are not limited to: growth factors that modulate tyrosine 
phosphorylation cycles, integrins, hyperosmotic stress or cell shrinkage, protein kinase C 
(PKC), tyrosine phosphorylation cascades and heterotrimeric G proteins (Clark & Limbird, 
1991; Barber, 1991; Rozengurt, 1986; Lowe et al., 1990). Those similarities provide evidence 
to suggest that ERK may be a direct proximal component of an NHE regulatory pathway 
(Noel & Pouyssegur, 1995; Aharonovitz & Granot, 1996). There is a growing awareness that 
tyrosine phosphorylation cycles are critical in regulating NHE activities in a number of cell 
types (Donowitz et al., 1994; Yamaji et al., 1995; Good, 1995; Fukushima et al., 1996) as has 
also been shown for ERK (Blumer & Johnson, 1994). Other studies have demonstrated that 
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NHE and ERK activities are modulated by overlapping upstream enzymes, including 
phosphoinositide 3´-kinase (PI-3K), phospholipase C, and PKC (Levine et al., 1993; Kapus et 
al., 1994; Voyno-Yasenetskaya et al., 1994; Bertrand et al., 1994; Ma et al., 1994; 
Dhanasekaran et al., 1994; Inglese et al., 1995). In aggregate, those studies implicate G 
proteins, lipid-recognizing enzymes, tyrosine kinases, and NHEs as playing interrelated 
roles along with ERK in cell growth (Barber, 1991; Noel & Pouyssegur, 1995; Aharonovitz & 
Granot, 1996; Blumer & Johnson, 1994; Lin et al., 1996). Relevant to the hypothesis that ERK 
regulates NHE1, are studies showing that microinjection of activated Ras (Hagag et al., 
1987) or transfection of the Ha-Ras oncogene (Doppler et al., 1987; Maly et al., 1989; Kaplan 
& Boron, 1994) stimulates NHE activity in fibroblasts. The classical effect of GTP-bound Ras 
is the activation of the ERK1 and ERK2 (Blumer & Johnson, 1994). This is thought to occur 
primarily through a linear signalling pathway that flows as follows: Ras-GTP → Raf-1 
kinase → MEK (MAPK/ERK kinase) → ERK. Thus, because Ras functions upstream of both 
NHE and ERK activities, ERK has been proposed as a logical funnel for signals from 
extracellular stimuli to the effector NHE. The effect of NHE activation due to the sustained 
activation of ERK is most likely secondary to the  activation of transcription cascades that 
upregulate the NHE message/protein or modulate expression of key regulators of NHE 
activity. However, several studies suggest that ERK might regulate NHE activity in the 
short term, as well. The possibility that ERK rapidly regulates NHE activity was tested in 
platelets by Aharonovitz and Granot (Aharonovitz & Granot, 1996) who showed that 
arginine vasopressin (AVP) and PMA rapidly activated NHE by a pathway which was 
sensitive to PD98059, a specific inhibitor of MEK1. Moreover, the signal initiated by AVP 
was sensitive to genistein, a broad-spectrum inhibitor of tyrosine kinases (Aharonovitz & 
Granot, 1996). Bianchini et al. (Bianchini et al., 1997) went further to characterize the role of 
ERK in regulating NHE when cells  were stimulated  by combinations of growth factors or 
serum. Specifically, they showed that expression of a dominant negative p44 ERK or of the 
MAPK phosphatase MKP-1, or treatment with the MEK1 inhibitor PD98059 reduced 
activation of NHE-1 by mixtures of growth factors by about 50%.  Further, it has been 
shown that short-term activation of ERK leads to rapid stimulation of NHE1 in multiple cell 
types (erythrocytes, fibroblasts, MDCK-11 cells, rabbit skeletal muscle, and cultured rat 
neonatal and adult ventricular cardiomyocytes) when activated by diverse stimuli including 
growth factors, angiotensin II, and aldosterone (Wang et al., 1997; Sabri et al., 1998; 
Bouboula et al., 1999; Gekle et al., 2001; Wei et al., 2001; Moor et al., 2001; Snabaitis et al., 
2002). At least in some cases, the short term-stimulation of NHE1 by ERK is mediated by 
phosphorylation of NHE1 either by ERK itself, or by p90RSK, an ERK-regulated kinase 
(Takahashi et al., 1999). Cuello et al. demonstrated that ERK- dependent 90kDa ribosomal S6 
kinase (RSK) is the principal regulator of cardiac sarcolemmal NHE1 phosphorylation and 
NHE activity after ǂ1-adrenergic stimulation in adult myocardium (Cuello et al., 2007). 
Thus, there is clear evidence that ERK can increase the activity of NHE1 by increasing its 
expression and/or by stimulating the activity of existing NHE1 molecules. 
2.3.2 MAPK and NHE1 do not regulate each other 
On the other hand, several groups have been unable to show any role for ERK in activating 
NHE1 in multiple cell types, including Xenopus oocytes (Kang et al., 1998), Ehrlich Ascites 
cells (Pederson et al., 2002), CHO cells (Garnovskaya et al., 1998), or hepatic stellate cells (Di 
Sario et al., 2003). Moreover, there is one report in which ERK was shown to mediate 
inhibition of NHE1 activity in MTAL cells (Watts & Good, 2002). Our group tested the 
hypothesis that ERK could mediate rapid, short-term activation of NHE activity in 
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fibroblasts when both signals were initiated by a single G protein-coupled serotonin 5-HT1A 
receptor (Garnovskaya et al., 1998). These studies revealed a number of similarities between 
the regulation of ERK and NHE. Activation of the two processes shared similar 
concentration–response and time-course characteristics. Receptor-activated NHE and ERK 
also shared an overlapping sensitivity to some pharmacological inhibitors of tyrosine 
kinases (staurosporine and genistein), PI-3K (wortmannin and LY294002), and PC-PLC 
(D609), and neither pathway was sensitive inhibition of PKC. However, definitive studies 
designed to block signaling molecules possessing well-defined roles in activating ERK 
through the 5-HT1A receptor by transfecting cDNA constructs encoding inactive mutant PI-
3K, Grb2, Sos, Ras, and Raf molecules were successful in attenuating ERK, but had 
essentially no effect upon NHE activation. Thus, our data do not support the hypothesis that 
ERK is a proximal short-term regulator of NHE in CHO cells when the signal is initiated by 
the Gi/o/z protein-coupled 5-HT1A receptor. Therefore, the ability of ERK to stimulate NHE1 
activity has not been a universal finding.  
2.3.3 NHE1 as a regulator of MAPK 
Despite the increasing interest in potential roles for ERK in the activation of NHE1, much less 
is known regarding the role of NHE1 in regulating ERK. There have been several reports that 
suggest that NHE1 might play a role in regulating ERK activation (reviewed by Pedersen et al., 
2007). Mitsuka et al. had shown that specific inhibitors of NHE1 could reduce neointimal 
proliferation in a rat model of carotid artery injury (Mitsuka et al., 1993). However, in C6 
glioma cells although lysophosphatidic acid (LPA) - increased proliferation was sensitive to 
NHE1 inhibitors, LPA-induced ERK activation was unaffected (Cechin et al., 2005).  Takewaki 
et al. presented some evidence that a potent antagonist of NHE1 could partially inhibit stretch-
induced activation of ERK in the cultured cardiomyocytes (Takewaki et al., 1995). Later the 
same group reported that in cultured neonatal rat cardiomyocytes NHE1 inhibition blocked 
the stretch-induced activation of Raf-1 and ERK, while angiotensin II (Ang II)- and endothelin 
1-induced ERK activation remained unaffected (Yamazaki et al., 1998).  On the other hand, our 
work in vascular smooth muscle cells (VSMC) demonstrated that activation of ERK by AII and 
serotonin was strongly dependent of NHE1 activity, and the effect of NHE1 occurs at or above 
the level of Ras (Mukhin et al., 2004). In human colon cancer epithelial cells, NHE1 inhibition 
suppressed activation of ERK and NF-κB and led to decreased production of interleukin-8 in 
response to inflammatory signals (Nemeth et al., 2002). Recently it has been also demonstrated 
that NHE1 inhibition prevented ERK activation during phenylephrine-induced hypertrophy 
in neonatal rat cardiomyocytes (Javadov et al., 2006), and prevented glucose-induced ERK 
activation in a high glucose model of cardiomyocyte hypertrophy (Chen et al., 2007). In Ehrlich 
Lettre Ascites cells under osmotic cell shrinkage NHE1 regulates ERK acting at or above the 
level of MEK (Pederson et al., 2002). Therefore, NHE1-dependent regulation of ERK in most 
cases has been described in cells stimulated by mechanical stretch, osmotic shrinkage, 
hypertrophy and inflammatory mediators (Takewaki et al., 1995; Nemeth et al., 2002; 
Yamazaki et al., 1998; Javadov et al., 2006; Chen et al., 2007; Mitsuka et al., 1993; Pederson et 
al., 2007). Very little is known about GPCR-induced NHE1-dependent ERK regulation. One 
report suggests that NHE1 is not a regulator for LPA-induced ERK activation in C6 glioma 
cells (Cechin et al., 2005) and another paper demonstrates the lack of role of NHE1 in AII- and 
endothelin 1-induced ERK activation in cultured neonatal rat cardiomyocytes (Chen et al., 
2007).  
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2.3.3.1 NHE1 regulates ERK activity in GPCR-activated VSMC 
Angiotensin II (Ang II), a potent hypertrophic factor for vascular smooth muscle cells, 
mediates its effects via specific plasma membrane AT1 receptors that belong to GPCR family. 
Ang II stimulates multiple signaling pathways (reviewed by Touyz & Schiffrin, 2000) 
including MAPKs, Src family kinases, phospholipase D, and Janus kinase (Jak2). Ang II also 
has been shown to stimulate NHE1 activity in VSMC (Berk et al., 1987) but does not appear 
to increase the steady state levels of NHE1 mRNA. There also are reports on relationship 
between Ang II-induced NHE1 and ERK activities in VSMC suggesting that activation of the 
AT1 receptor first leads to activation of the MEK-ERK-p90RSK pathway, and that activated 
p90RSK in turn directly phosphorylates and activates NHE1 in VSMC (Takewaki et al., 
1995).  However, this suggestion was based mainly on in vitro experiments in which p90RSK 
immunoprecipitated from Ang II-stimulated VSMC was able to phosphorylate recombinant 
NHE1, and  it is still not clear whether Ang II-induced phosphorylation of NHE1 takes place 
in VSMC in vivo and if this phosphorylation is physiologically significant. Our group has 
described a novel pathway of the regulation of NHE1 activity in VSMC by two mitogens, 
Ang II and serotonin (5-HT) that involves the activation of Jak2, tyrosine phosphorylation of 
Ca2+/calmodulin, and binding of calmodulin (CaM) to NHE-1 (Garnovskaya et al., 2003). In 
the same study we were not able to support any role for ERK in Ang II-induced NHE1 
activation in VSMC (Garnovskaya et al., 2003). Further, we specifically investigated the roles 
of NHE and ERK (as stimulated by either 5-HT or Ang II) in the activation of each other in 
VSMC (Mukhin et al., 2004), and we have found evidence to support a novel role for NHE in 
the activation of ERK in VSMC. This evidence includes 1) dual stimulation of NHE and ERK 
by Ang II and 5-HT, with the activation of NHE preceding that of ERK, 2) similar 
concentration-response relationships for the stimulation of NHE and the phosphorylation of 
ERK by 5-HT and Ang-II, 3) blockade of the activation of ERK induced by 5-HT and Ang II 
by chemical inhibition of NHE, 4) blockade of the activation of ERK induced by 5-HT and 
Ang II by removal of sodium from incubation buffers, and 5) phosphorylation of ERK 
during recovery from an imposed acid load, a maneuver that induces receptor-independent 
activation of NHE.  
Moreover, in the case of receptor-induced activation of ERK, NHE appears to be located 
upstream of MEK and ERK, and downstream of Ang II and 5-HT-mediated transactivation 
of the EGF receptor. NHE intersects the classical pathway of activation of ERK at or above 
the level of Ras. Figure 3 depicts one possible scheme that can account for our findings. 
Because it has been described that Gq-coupled receptors such as  Ang II AT1  and serotonin 
5-HT2A receptors activate ERK in VSMC through transactivation and phosphorylation of the 
epidermal growth factor (EGF) receptor (Eguchi et al., 1999), we wanted to establish 
whether NHE regulates ERK activation upstream of the EGF receptor. It appeared that  
inhibition of NHE activity by depriving the exchanger of extracellular sodium, or by 
blockade with the specific inhibitors, amiloride analog, methylisobutylamiloride (MIA), 
prevents activation of ERK by two GPCR ligands, Ang II and 5-HT. Those same maneuvers 
have no effect on EGF-stimulated ERK, suggesting that there are some differences in the 
pathways used by Ang II and 5-HT to activate ERK when compared with that used by EGF. 
Interestingly, the close connection between NHE and ERK activation is further underscored 
by the observation that receptor-independent activation of NHE also results in ERK 
phosphorylation only when the exchanger is allowed to mediate recovery from an imposed 
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intracellular acid load. Thus, NHE activation is necessary for Ang II and 5-HT-induced 
activation of ERK, and is sufficient to activate ERK under conditions of an imposed acid load. 
In contrast, NHE activation is not necessary for EGF-mediated activation of ERK. The most 
likely explanation is that 5-HT or Ang II requires the parallel activation of NHE and the 
EGFR to activate ERK in VSMC. The two pathways intersect downstream of trans-
phosphorylation of the EGFR, and upstream of ERK and MEK, most likely at or upstream of 
Ras ( Figure 3). The precise mechanisms of NHE-dependent ERK activation by Ang II and 5-
HT remain to be defined. One  possibility is that NHE plays an accessory role in Ang II and 
5-HT induced activation of ERK by facilitating cytoskeletal reorganization or by altering Na+ 
or H+ concentrations in cellular microdomains, thereby affecting enzyme activity or protein-
protein interactions. 
 
Fig. 3. Hypothetical scheme of NHE1-dependent ERK activation by GPCRs in VSMC. 
The speculation regarding the cytoskeletal effects of NHE is particularly intriguing in light 
of work by Barber’s group showing important functional links between NHE activity and 
the cytoskeleton (Denker et al., 2000). These findings have potential implications for the 
regulation of vascular tone, as well as for vascular pathobiology because Ang II and 5-HT 
are both potent vasoconstrictors, and Ang II has been shown to play major roles in various 
cardiovascular diseases including left ventricular hypertrophy and hypertension (Mitsuka et 
al., 1993).  
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2.3.3.2 NHE1 regulates ERK activity in Bradykinin-activated renal carcinoma cells 
Because we have been able to detect the critical role of NHE in GPCR-mediated activation 
of ERK in cells of contractile phenotype, we thought that this relationship might be 
restricted to specific cell types and receptors. The cellular specificity of the relationship 
between NHE1 and ERK could be mediated by alternate accessory components of each 
signaling pathway, or by cell-specific compartmentalization of scaffolded signal 
transduction platforms (Luttrell & Lutrell, 2003). However, we have collected data that 
support a role of NHE1 in bradykinin B2 receptor-induced ERK activation in renal 
carcinoma A498 cells, thus suggesting that the critical role of NHE1 in GPCR-induced 
ERK activation is not restricted to one specific cell type and receptor (Garnovskaya et al., 
2008). In this study we investigated the endogenous intrarenal kinin hormone bradykinin 
(BK) that exerts its multiple pathophysiological functions via two known receptors, the 
bradykinin B1 (BK B1) and bradykinin B2 (BK B2) which belong to the superfamily of G 
protein-coupled receptors (GPCR) (Hess et al., 1992; Menke et al., 1994; Bagate et al., 
2001).  BK plays a significant role as a modulator of renal function such as electrolyte and 
water excretion (Mukai et al., 1996) as well as in renal cell growth and proliferation (El-
Dahr et al., 1998; Jaffa et al., 1997). We have previously reported that BK activates NHE1 
in a kidney cell line derived from the inner medullary collecting duct of mice (mIMCD-3 
cells) (Mukhin et. al., 2001) via the similar pathway that Ang II and serotonin employ to 
activate NHE1 activity in VSMC, which involves the activation of Jak2, tyrosine 
phosphorylation of Ca2+/calmodulin, and binding of calmodulin (CaM) to NHE-1 
(Garnovskaya et al., 2003).  We have also described that BK is a potent mitogenic factor for  
mIMCD-3 cells, and demonstrated that BK-induced cell proliferation was dependent on 
activation of epidermal growth factor receptor (EGFR) tyrosine kinase and subsequent 
activation of mitogen- and extracellular signal-regulated kinase kinase (MEK) and 
(Mukhin et al., 2003; Mukhin et al., 2006; Kramarenko et al., 2010). However, we were not 
able to establish the relationship between NHE1 and ERK in mIMCD-3 cells. Our data did 
not support either the hypothesis that ERK is a proximal short-term regulator of NHE or 
the hypothesis that NHE1 is necessary for the BK-induced ERK activation in normal 
kidney mIMCD-3 cells  (Garnovskaya, unpublished data).  Because there is evidence 
linking BK to the cancerogenic process (Bhoola et al., 2001; Chan et al., 2002), and because 
NHE1 has been proposed to play role in cancer cells growth (Cardone et al., 2005 ), we 
wanted to explore the possibility that BK exerts its mitogenic effects via activation of NHE 
in cancer cell lines. The expression of BK receptors has been demonstrated in clinical 
speciments of adenocarcinoma, squamous carcinoma, lymphoma, hepatoma and 
carcinoid, and in experimental mouse sarcoma 180 and colon adenocarcinoma 38 (Wu et 
al., 2002), in small cell and non-small cell carcinomas of the lung (Chee et al., 2008), and in 
oesophageal squamous cell carcinoma (Dlamini et al., 2005). The mitogenic effects of BK 
have been reported in primary cultured epithelial breast cancer cells and in MCF-7 breast 
cancer cell line, where BK stimulated cell proliferation through ERK activation (Greco et 
al., 2005; Greco et al., 2006). Because there were limited studies on the role of BK in renal 
cell carcinomas, we have chosen to use A498 cells, a transformed cell line derived from 
primary undifferentiated kidney carcinoma (Giard et al., 1973), which represents a widely 
used model for studying of renal carcinomas.  Our results demonstrated that NHE1 is 
involved in BK-induced ERK activation and proliferation of A498 cells, and that BK B2 
receptor-induced ERK activation in A498 cells depends on NHE activity (Garnovskaya et 
 
www.intechopen.com
 Current Frontiers and Perspectives in Cell Biology 248 
al., 2008), suggesting that the critical role of NHE1 in GPCR-induced ERK activation is not 
restricted to one specific cell type and receptor.  Previously, NHE1-mediated intracellular 
alkalinization has been proposed to play role in cancer cells growth because it has been 
shown that increased pHi of tumor cells is associated with increased in vivo tumor growth, 
DNA synthesis, and cell-cycle progression, suggesting that over-expression of NHE1 
contributes to the transformed phenotype of multiple cancer cells (reviewed by Cardone 
et al., 2005 ). The cellular alkalinization of tumor cells induced by hyperactivation of 
NHE1 has been shown to be directly related to increased protein synthesis and tumor cell 
growth (Cardone et al., 2005; Harguindey et al., 2005). It has been suggested that the 
mechanism of NHE1-mediated tumor cell growth and metastasis does not depend of its 
ion-transporting activities but rather employs NHE1 as a scaffolding protein to directly 
regulate cytoskeletal dynamics (Cardone et al., 2005).  Further it has been shown that 
NHE1 antisense gene suppresses cell growth, induces cell apoptosis, and partially 
reverses the malignant phenotypes of human gastric carcinoma cells (Liu et al., 2008).  
Similarly, silencing of NHE1 gene by siRNA interference and /or inhibition of NHE1 
activity by amiloride analogs effectively blocked the invasiveness of human 
hepatocellular carcinoma cells (Yang et al., 2011). Thus, inhibition of NHE1 might result in 
an antiproliferative effect, and NHE1 may be a potential target for chemotherapeutics to 
treatment of renal carcinoma. 
3. Conclusion 
The elucidation and understanding of the relationship between NHE1 and ERK cascade has 
been one of the most active areas in biological research over the past few years. As discussed 
above, experimental studies have strongly implicated a role for NHE1 in the regulation of 
ERK activity, although the precise pathway, which leads from the activation of NHE1 to 
ERK regulation still has to be defined.  One possibility is that GPCR-induced NHE1-
dependent ERK activation depends on NHE1-mediated Na+/H+ exchange. In that sense, 
Grinstein et al have demonstrated uneven distribution of NHE1 molecules throughout the 
cell surface with the focal accumulation at or near terminal edges of fibroblasts and CHO 
cells, and the areas of increased NHE1 density closely corresponded to sites of accumulation 
of cytoskeletal proteins (Grinshtein et al., 1993). It is possible that NHE1 regulates ERK by 
altering Na+ or H+ concentrations in cellular microdomains, thereby affecting enzyme 
activity or protein-protein interactions. Another possibility is that NHE1 acts as a plasma 
membrane scaffold  (Baumgartner et al., 2004) in the assembly of signaling complexes 
independent of its ion exchange activity bringing together GPCRs, and the members of 
ERK-activation cascade. Regardless of the mechanisms, the critical role of NHE1 as an 
upstream molecule in GPCR-induced ERK activation  could have significant physiological 
and pathophysiological relevance.   
Because ERK-dependent cell proliferation is thought to be a critical component in many 
pathologic conditions, and NHE is involved in a variety of complex physiological and 
pathological events that include regulation of intracellular pH, cell movement, heart disease, 
and cancer, improved understanding of the molecular mechanisms that regulate NHE  and 
ERK may allow alternative approaches to the therapeutic manipulation of  ERK and NHE 
activity to be developed.  
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